发明名称 STABLE AND FILTERABLE ENVELOPED VIRUS FORMULATION
摘要 <P>PROBLEM TO BE SOLVED: To provide a formulation of live therapeutic viruses and live virus vaccines. <P>SOLUTION: Envelope viruses (e.g., Newcastle disease virus (NDV)) are formulated for storage at moderately cold temperatures (e.g., -20&deg;C). The formulation is an aqueous solution containing the enveloped virus at a concentration of from 10<SP POS="POST">6</SP>PFU/mL to 10<SP POS="POST">12</SP>PFU/mL; and a non-reducing saccharide (e.g., sucrose). When the non-reducing saccharide is a disaccharide it is present in the solution at a concentration of from 5% (w/v) to 50% (w/v), and when it is a monosaccharide it is present in the solution at a concentration of from 2.5% (w/v) to 25% (w/v). The solution has an osmotic pressure of about 250 mOs or higher, and has a pH of from 5 to 10. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012214518(A) 申请公布日期 2012.11.08
申请号 JP20120179515 申请日期 2012.08.13
申请人 WELLSTAT BIOLOGICS CORP 发明人 CHEN TZER-FEN;JANG JOUHN-WERN;MILLER JEFFREY A
分类号 A61K39/155;A61K9/08;A61K47/18;A61K47/26;A61P31/14 主分类号 A61K39/155
代理机构 代理人
主权项
地址